Koenig also emphasizes that VSL#3 is unparalleled in the probiotic market, highlighting its specific formulation tailored for IBS, ulcerative colitis and fatty liver disease
Many women have ovarian cysts at some point in their life
There is no oral form of this blend that survives digestion, which is another reason the protocol is framed entirely around a small subcutaneous dose
Semaglutide trials (STEP 1-4) demonstrated 15-22% weight loss over 68 weeks, while tirzepatide (SURMOUNT trials) showed 20-24% weight loss at the highest doses
The full secondary analysis is unavailable, so it is not entirely clear what the research limitations are
Symptoms suggesting thyroid abnormalitiesincluding a neck mass, persistent hoarseness, dysphagia, or dyspnearequire evaluation, given the medication's boxed warning regarding thyroid C-cell tumors observed in rodent studies (though human relevance remains uncertain)